[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.226.244.70. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 8, 1917

END MONOPOLY ON SALVARSAN

JAMA. 1917;LXIX(10):843. doi:10.1001/jama.1917.02590370079038

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor:  —To the communication of Dr. S. Pollitzer (The Journal, July 28, 1917, p. 305) concerning the price of salvarsan in this country, I wish to add one thing, and I will ask a few questions.In Athens, Greece, in 1913, I used to buy either salvarsan or neosalvarsan, the full dose, 0.9 gm., for 8 drachmas, or $1.55, and the minimum dose, 0.45 gm., for 4.50 drachmas, or $0.89, and the same drugs were sold to the hospitals for 20 per cent. less.What then, makes the price of salvarsan in the United States so high? Does it pay duty? How much does the same thing cost in Germany? What is the price of arsenobenzol in comparison of that of salvarsan if "the chemicals that enter cost normally only a few dollars per pound"? Why pay $3 per 0.3 gm. of galyl, another arsenical, in this country?

First Page Preview View Large
First page PDF preview
First page PDF preview
×